Want to see PALI full AI Analyst Report?
Palisade Bio (PALI) Income Statement
Palisade Bio Income Statement
Last quarter (Q2 2026), Palisade Bio's total revenue was $500.00K. In Q2, Palisade Bio's net income was $-10.57M. See Palisade Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 250.00K | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 250.00K | $ 0.00 | $ 0.00 | |
| $ 18.06M | $ 14.86M | $ 13.32M | $ 15.72M | $ 41.85M | |
| Depreciation and Amortization | $ 3.00K | $ 3.00K | $ 4.00K | $ 3.00K | $ 2.00K |
| $ -16.77M | $ -14.42M | $ -12.28M | $ -14.24M | $ -24.22M | |
| $ -18.06M | $ -14.86M | $ -13.07M | $ -15.72M | $ -41.85M | |
| $ 1.27M | $ 421.00K | $ 770.00K | $ 1.46M | $ 15.24M | |
| $ -16.78M | $ -14.44M | $ -12.30M | $ -14.26M | $ -26.62M | |
| $ -16.78M | $ -14.44M | $ -12.30M | $ -14.26M | $ -26.62M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.30 | $ -10.19 | $ -27.01 | $ -16.53 | $ -2144.25 |
| Diluted EPS | $ -0.30 | $ -10.19 | $ -27.01 | $ -16.53 | $ -2546.10 |
| Weighted Average Shares Outstanding | 55.67M | 1.42M | 456.01K | 880.10K | 12.41K |
| Weighted Average Shares Outstanding (Diluted) | 55.67M | 1.42M | 456.01K | 880.30K | 12.46K |
Currency in USD
